US Stock MarketDetailed Quotes

DRMA Dermata Therapeutics

Watchlist
  • 1.2900
  • +0.0719+5.90%
Close Nov 5 16:00 ET
  • 1.3000
  • +0.0100+0.78%
Pre 04:58 ET
1.95MMarket Cap-68P/E (TTM)

Dermata Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-15.52%-2.13M
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
Net income from continuing operations
-66.28%-2.83M
-39.91%-3.13M
18.90%-7.79M
-27.81%-2.13M
29.09%-1.72M
37.69%-1.7M
19.60%-2.24M
-21.62%-9.61M
34.60%-1.67M
-41.55%-2.42M
Change In working capital
353.00%683.55K
-134.28%-157.43K
662.38%863.68K
327.75%858.2K
50.60%-183.59K
-142.92%-270.18K
1,428.23%459.25K
-153.04%-153.58K
-244.80%-376.82K
41.92%-371.67K
-Change in prepaid assets
7.63%273.38K
-46.00%94.42K
33.42%162.7K
-26.10%151.4K
18.05%-417.55K
-44.12%254K
726.18%174.85K
116.26%121.94K
-20.38%204.87K
-36.68%-509.52K
-Change in payables and accrued expense
178.25%410.17K
-188.55%-251.85K
354.43%700.98K
221.51%706.8K
69.71%233.96K
-399.58%-524.17K
4,374.78%284.4K
-126.50%-275.52K
-20,034.51%-581.69K
151.60%137.85K
Cash from discontinued investing activities
Operating cash flow
-15.52%-2.13M
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
54.71%2.34M
0
77.84%7.61M
1.95M
-17,809.50%-35.42K
-64.64%1.51M
4.18M
-73.21%4.28M
0
-100.00%200
Net common stock issuance
59.34%2.41M
--0
77.85%7.61M
--1.95M
---35.42K
-64.64%1.51M
--4.17M
-72.21%4.28M
--0
--0
Proceeds from stock option exercised by employees
--0
--0
-34.84%187
--0
--0
-60.92%34
--153
--287
--0
--200
Cash from discontinued financing activities
Financing cash flow
54.71%2.34M
--0
77.84%7.61M
--1.95M
-17,809.50%-35.42K
-64.64%1.51M
--4.18M
-73.21%4.28M
--0
-100.00%200
Net cash flow
Beginning cash position
-46.00%4.73M
19.18%7.44M
-42.20%6.24M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
1,935.97%10.8M
-35.99%8.07M
2,387.79%10.63M
Current changes in cash
165.02%213.42K
-207.09%-2.7M
126.26%1.2M
144.19%806.65K
29.44%-1.81M
-113.47%-328.23K
196.84%2.53M
-144.38%-4.56M
-1.16%-1.83M
-121.03%-2.56M
End cash Position
-41.37%4.95M
-46.00%4.73M
19.18%7.44M
19.18%7.44M
-17.79%6.63M
-20.60%8.44M
7.03%8.77M
-42.20%6.24M
-42.20%6.24M
-35.99%8.07M
Free cash flow
-15.52%-2.13M
-63.94%-2.7M
27.45%-6.41M
37.15%-1.15M
30.83%-1.77M
-0.05%-1.84M
36.74%-1.65M
-55.17%-8.83M
-1.20%-1.83M
-15.89%-2.56M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Audit Opinions
--
--
Unqualified Opinion with Explanatory Notes
--
--
--
--
Unqualified Opinion with Explanatory Notes
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -15.52%-2.13M-63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M
Net income from continuing operations -66.28%-2.83M-39.91%-3.13M18.90%-7.79M-27.81%-2.13M29.09%-1.72M37.69%-1.7M19.60%-2.24M-21.62%-9.61M34.60%-1.67M-41.55%-2.42M
Change In working capital 353.00%683.55K-134.28%-157.43K662.38%863.68K327.75%858.2K50.60%-183.59K-142.92%-270.18K1,428.23%459.25K-153.04%-153.58K-244.80%-376.82K41.92%-371.67K
-Change in prepaid assets 7.63%273.38K-46.00%94.42K33.42%162.7K-26.10%151.4K18.05%-417.55K-44.12%254K726.18%174.85K116.26%121.94K-20.38%204.87K-36.68%-509.52K
-Change in payables and accrued expense 178.25%410.17K-188.55%-251.85K354.43%700.98K221.51%706.8K69.71%233.96K-399.58%-524.17K4,374.78%284.4K-126.50%-275.52K-20,034.51%-581.69K151.60%137.85K
Cash from discontinued investing activities
Operating cash flow -15.52%-2.13M-63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities 54.71%2.34M077.84%7.61M1.95M-17,809.50%-35.42K-64.64%1.51M4.18M-73.21%4.28M0-100.00%200
Net common stock issuance 59.34%2.41M--077.85%7.61M--1.95M---35.42K-64.64%1.51M--4.17M-72.21%4.28M--0--0
Proceeds from stock option exercised by employees --0--0-34.84%187--0--0-60.92%34--153--287--0--200
Cash from discontinued financing activities
Financing cash flow 54.71%2.34M--077.84%7.61M--1.95M-17,809.50%-35.42K-64.64%1.51M--4.18M-73.21%4.28M--0-100.00%200
Net cash flow
Beginning cash position -46.00%4.73M19.18%7.44M-42.20%6.24M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M1,935.97%10.8M-35.99%8.07M2,387.79%10.63M
Current changes in cash 165.02%213.42K-207.09%-2.7M126.26%1.2M144.19%806.65K29.44%-1.81M-113.47%-328.23K196.84%2.53M-144.38%-4.56M-1.16%-1.83M-121.03%-2.56M
End cash Position -41.37%4.95M-46.00%4.73M19.18%7.44M19.18%7.44M-17.79%6.63M-20.60%8.44M7.03%8.77M-42.20%6.24M-42.20%6.24M-35.99%8.07M
Free cash flow -15.52%-2.13M-63.94%-2.7M27.45%-6.41M37.15%-1.15M30.83%-1.77M-0.05%-1.84M36.74%-1.65M-55.17%-8.83M-1.20%-1.83M-15.89%-2.56M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Audit Opinions ----Unqualified Opinion with Explanatory Notes--------Unqualified Opinion with Explanatory Notes----

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data